- Article
Exploring the Potential of Lapatinib, Fulvestrant, and Paclitaxel Conjugated with Glycidylated PAMAM G4 Dendrimers for Cancer and Parasite Treatment
- Łukasz Uram,
- Konrad Wróbel,
- Małgorzata Walczak,
- Żaneta Szymaszek,
- Magdalena Twardowska and
- Stanisław Wołowiec
Fulvestrant (F), lapatinib (L), and paclitaxel (P) are hydrophobic, anticancer drugs used in the treatment of estrogen receptor (ER) and epidermal growth factor receptor (EGFR)-positive breast cancer. In this study, glycidylated PAMAM G4 dendrimers,...